MedTrace Logo

Comparison of Chitosan, Ankaferd and Tranexamic Acid in Dental Extraction in Liver Pre-Transplant Children

NCT06457360 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2024-10-18

No results posted yet for this study

Summary

The aim of the present study is:

To assess the hemostatic effect of chitosan-based dressing, Ankaferd and Tranexamic acid after extraction in children with end stage liver diseases where the:

• Primary objective: is to evaluate which of the previous materials will be the most effective as a hemostatic agent

Conditions

Interventions

DRUG

tranexamic acid

Application of sterile gauze after extraction for hemostasis

DRUG

Ankaferd Blood Stopper

Application of sterile gauze after extraction for hemostasis

DRUG

Chitosan

Application of sterile gauze after extraction for hemostasis

Sponsors & Collaborators

  • British University In Egypt

    lead OTHER

Principal Investigators

  • noha S Kabil · British University In Egypt

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
4 Years
Max Age
9 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-15
Primary Completion
2024-01-20
Completion
2024-05-20

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06457360 on ClinicalTrials.gov